HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- benzoylpyridine- 4,4- dimethyl- 3- thiosemicarbazone

structure in first source

Also Known As:

Bp44mT

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone: 2
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiosemicarbazones: 649
    - 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone: 2
- Semicarbazides: 7
  - Semicarbazones: 67
    - Thiosemicarbazones: 649
      - 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone: 2

Experts

1.	Richardson, D R: 2 articles (01/2012 - 01/2012)
2.	Suryo Rahmanto, Y: 2 articles (01/2012 - 01/2012)
3.	Yu, Y: 2 articles (01/2012 - 01/2012)
4.	Gutierrez, E: 1 article (01/2012)
5.	Kovacevic, Z: 1 article (01/2012)
6.	Obeidy, P: 1 article (01/2012)
7.	Saletta, F: 1 article (01/2012)

Related Diseases

1.	Weight Loss (Weight Reduction) 01/01/2012 - "There was also no significant weight loss in mice, suggesting oral administration of Bp44mT was well tolerated. "
2.	Neoplasms (Cancer) 01/01/2012 - "Moreover, unlike typical iron chelators which simply act to deplete tumors of iron, several thiosemicarbazones (i.e., Bp44mT and Dp44mT) do not induce this effect, their anti-cancer efficacy being due to other mechanisms e.g., redox activity. "

Related Drugs and Biologics

1.	Thiosemicarbazones
2.	Iron
3.	Chelating Agents
4.	di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazone

Related Therapies and Procedures

1.	Oral Administration